Hopkins AM - Search Results

1

C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab.

Abuhelwa AY, Bellmunt J, Kichenadasse G, McKinnon RA, Rowland A, Sorich MJ, Hopkins AM. Abuhelwa AY, et al. Among authors: hopkins am. Front Oncol. 2022 Aug 1;12:918993. doi: 10.3389/fonc.2022.918993. eCollection 2022. Front Oncol. 2022. PMID: 35978814 Free PMC article.

2

Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia.

Hopkins AM, Proudman SM, Vitry AI, Sorich MJ, Cleland LG, Wiese MD. Hopkins AM, et al. Med J Aust. 2016 Feb 1;204(2):64-8. doi: 10.5694/mja15.00716. Med J Aust. 2016. PMID: 26821102

3

Population Pharmacokinetic Model of Doxycycline Plasma Concentrations Using Pooled Study Data.

Hopkins AM, Wojciechowski J, Abuhelwa AY, Mudge S, Upton RN, Foster DJ. Hopkins AM, et al. Antimicrob Agents Chemother. 2017 Feb 23;61(3):e02401-16. doi: 10.1128/AAC.02401-16. Print 2017 Mar. Antimicrob Agents Chemother. 2017. PMID: 28052851 Free PMC article.

4

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers.

Hopkins AM, Rowland A, Kichenadasse G, Wiese MD, Gurney H, McKinnon RA, Karapetis CS, Sorich MJ. Hopkins AM, et al. Br J Cancer. 2017 Sep 26;117(7):913-920. doi: 10.1038/bjc.2017.274. Epub 2017 Aug 24. Br J Cancer. 2017. PMID: 28950287 Free PMC article. Review.

5

Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug Exposure.

Rowland A, van Dyk M, Hopkins AM, Mounzer R, Polasek TM, Rostami-Hodjegan A, Sorich MJ. Rowland A, et al. Among authors: hopkins am. Clin Pharmacol Ther. 2018 Dec;104(6):1219-1228. doi: 10.1002/cpt.1076. Epub 2018 Apr 19. Clin Pharmacol Ther. 2018. PMID: 29574693

6

Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.

Hopkins AM, Rowland A, Sorich MJ. Hopkins AM, et al. BMC Med. 2018 Sep 28;16(1):165. doi: 10.1186/s12916-018-1154-z. BMC Med. 2018. PMID: 30261889 Free PMC article.

7

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials.

Hopkins AM, Nguyen AM, Karapetis CS, Rowland A, Sorich MJ. Hopkins AM, et al. Cancers (Basel). 2018 Oct 15;10(10):384. doi: 10.3390/cancers10100384. Cancers (Basel). 2018. PMID: 30326638 Free PMC article.

8

Use of Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Axitinib Exposure: A Fresh Approach to Precision Dosing in Oncology.

Sorich MJ, Mutlib F, van Dyk M, Hopkins AM, Polasek TM, Marshall JC, Rodrigues AD, Rowland A. Sorich MJ, et al. Among authors: hopkins am. J Clin Pharmacol. 2019 Jun;59(6):872-879. doi: 10.1002/jcph.1377. Epub 2019 Jan 11. J Clin Pharmacol. 2019. PMID: 30633368

9

Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial data.

Hopkins AM, Van Dyk M, Rowland A, Sorich MJ. Hopkins AM, et al. Pigment Cell Melanoma Res. 2019 Jul;32(4):576-583. doi: 10.1111/pcmr.12773. Epub 2019 Feb 28. Pigment Cell Melanoma Res. 2019. PMID: 30758912

10

Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials.

Sorich MJ, Rowland A, Karapetis CS, Hopkins AM. Sorich MJ, et al. Among authors: hopkins am. J Thorac Oncol. 2019 Aug;14(8):1440-1446. doi: 10.1016/j.jtho.2019.04.006. Epub 2019 Apr 15. J Thorac Oncol. 2019. PMID: 30999110 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page